Special study designs: early escape, enrichment, studies in non-responders
Author:
- Robert J. TempleRTRobert J. Temple
- 1 January 1994
- journal article
- research article
- Published by Taylor & Francis in Communications in Statistics - Theory and Methods
- Vol. 23 (2) , 499-531
Abstract
In a number of situations, a simple randomized trial in unselected patients may not be possible or efficient. Randomized withdrawal of therapy in patients previously treated, studies that allow early escape/early advance of patients doing poorly, and enrichment of study populations with potential responders may increase the feasibility of a trial and its chances for success.Keywords
This publication has 11 references indexed in Scilit:
- Double-blind trial of aspirin in primary prevention of myocardial infarction in patients with stable chronic angina pectorisThe Lancet, 1992
- A Double-Blind, Placebo-Controlled Multicenter Study of Tacrine for Alzheimer's DiseaseNew England Journal of Medicine, 1992
- Mortality and Morbidity in Patients Receiving Encainide, Flecainide, or PlaceboNew England Journal of Medicine, 1991
- Preliminary Report: Findings from the Aspirin Component of the Ongoing Physicians' Health StudyNew England Journal of Medicine, 1988
- Protective Effects of Aspirin against Acute Myocardial Infarction and Death in Men with Unstable AnginaNew England Journal of Medicine, 1983
- Government Viewpoint of Clinical TrialsDrug Information Journal, 1982
- Nifedipine Therapy for Coronary-Artery SpasmNew England Journal of Medicine, 1980
- Total Suppression of Ventricular Arrhythmias by EncainideNew England Journal of Medicine, 1980
- A Clinical Trial Design Avoiding Undue Placebo TreatmentThe Journal of Clinical Pharmacology, 1975
- Surgery's Relevance to an Understanding of Basic BiologyJAMA, 1967